Work

Phase I Study of XK469R (NSC 698215), a Quinoxaline Phenoxypropionic Acid Derivative, in Patients with Refractory Hematological Malignancies.

Year: 2006

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v108.11.1952.1952

Authors: Wendy Stock, Samir D. Undevia, Stefan Faderl, Olotoyosi Odenike, Farhad Ravandi, Srdan Verstovsek, Elizabeth Rich, Lucy Godley, Gautam Borthakur, William Wierda, Andrew Artz, Diane Bennett, Jackie Ramirez, Richard A. Larson, Mark J. Ratain, Francis Giles

Institutions: University of Chicago, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2553409637

FWCI: 0.2

Cites:

Cited by: 1

Related to: 10